103 related articles for article (PubMed ID: 11269765)
1. Molecular markers in head and neck squamous cell carcinoma: their biological function and prognostic significance.
Smith BD; Haffty BG; Sasaki CT
Ann Otol Rhinol Laryngol; 2001 Mar; 110(3):221-8. PubMed ID: 11269765
[TBL] [Abstract][Full Text] [Related]
2. Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma.
Smith BD; Haffty BG
Radiat Oncol Investig; 1999; 7(3):125-44. PubMed ID: 10406054
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathogenesis of head and neck squamous cell carcinoma.
Hardisson D
Eur Arch Otorhinolaryngol; 2003 Oct; 260(9):502-8. PubMed ID: 12736744
[TBL] [Abstract][Full Text] [Related]
4. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of cyclin D1 expression in head and neck squamous cell carcinoma.
Gioacchini FM; Alicandri-Ciufelli M; Kaleci S; Magliulo G; Presutti L; Re M
Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):801-9. PubMed ID: 25516222
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetics of head and neck cancer.
Gleich LL; Salamone FN
Cancer Control; 2002; 9(5):369-78. PubMed ID: 12410176
[TBL] [Abstract][Full Text] [Related]
7. Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation.
Lothaire P; de Azambuja E; Dequanter D; Lalami Y; Sotiriou C; Andry G; Castro G; Awada A
Head Neck; 2006 Mar; 28(3):256-69. PubMed ID: 16284973
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.
Michalides R; van Veelen N; Hart A; Loftus B; Wientjens E; Balm A
Cancer Res; 1995 Mar; 55(5):975-8. PubMed ID: 7867006
[TBL] [Abstract][Full Text] [Related]
10. [Inactivation of p53 and amplification of cyclin D1 in squamous cell carcinomas of the head and neck].
Rodrigo Tapia JP; González Meana MV; García González LA; Coto E; García Pedrero J; Núñez Batalla F; Suárez Nieto C
Acta Otorrinolaringol Esp; 2002 Apr; 53(4):225-32. PubMed ID: 12185899
[TBL] [Abstract][Full Text] [Related]
11. Molecular markers of metastasis in squamous carcinomas.
Helliwell TR
J Pathol; 2001 Jul; 194(3):289-93. PubMed ID: 11439359
[TBL] [Abstract][Full Text] [Related]
12. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy.
Buffa FM; Bentzen SM; Daley FM; Dische S; Saunders MI; Richman PI; Wilson GD
Clin Cancer Res; 2004 Jun; 10(11):3745-54. PubMed ID: 15173081
[TBL] [Abstract][Full Text] [Related]
13. Genetic aberrations in oral or head and neck squamous cell carcinoma 3: clinico-pathological applications.
Scully C; Field JK; Tanzawa H
Oral Oncol; 2000 Sep; 36(5):404-13. PubMed ID: 10964046
[TBL] [Abstract][Full Text] [Related]
14. Image cytometry of cyclin D1: a prognostic marker for head and neck squamous cell carcinomas.
Liu SC; Zhang SY; Babb JS; Ridge JA; Klein-Szanto AJ
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):455-9. PubMed ID: 11352854
[TBL] [Abstract][Full Text] [Related]
15. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
Akervall J; Bockmühl U; Petersen I; Yang K; Carey TE; Kurnit DM
Clin Cancer Res; 2003 May; 9(5):1750-5. PubMed ID: 12738730
[TBL] [Abstract][Full Text] [Related]
16. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.
Masuda M; Suzui M; Yasumatu R; Nakashima T; Kuratomi Y; Azuma K; Tomita K; Komiyama S; Weinstein IB
Cancer Res; 2002 Jun; 62(12):3351-5. PubMed ID: 12067972
[TBL] [Abstract][Full Text] [Related]
17. Potential molecular prognostic markers in head and neck squamous cell carcinomas.
Quon H; Liu FF; Cummings BJ
Head Neck; 2001 Feb; 23(2):147-59. PubMed ID: 11303632
[TBL] [Abstract][Full Text] [Related]
18. Role of molecular markers and gene profiling in head and neck cancers.
Gold KA; Kim ES
Curr Opin Oncol; 2009 May; 21(3):206-11. PubMed ID: 19346943
[TBL] [Abstract][Full Text] [Related]
19. Clinical applications of the diagnosis of p53 alterations in squamous cell carcinoma of the head and neck.
Lopez-Martinez M; Anzola M; Cuevas N; Aguirre JM; De-Pancorbo M
Med Oral; 2002; 7(2):108-20. PubMed ID: 11887018
[TBL] [Abstract][Full Text] [Related]
20. Should there be more molecular staging of head and neck cancer to improve the choice of treatments and thereby improve survival?
Almadori G; Bussu F; Paludetti G
Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):117-26. PubMed ID: 18327030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
